FDA Inspection 961531 — bioMerieux, Inc.

bioMerieux, Inc. — FEI 3002769706

The FDA completed an inspection of bioMerieux, Inc. on January 5, 2016 in Durham, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). 14 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 5, 2016
Fiscal Year
2016
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Durham, NC (United States)

Citations

IDCFRDescription
1472121 CFR 820.70(g)(2)Periodic equipment inspections
1472221 CFR 820.40Procedures not adequately established or maintained
232721 CFR 820.22Quality audits - Lack of or inadequate procedures
235021 CFR 820.25(b)Training - Lack of or inadequate procedures
312021 CFR 820.80(a)Lack of or inadequate procedures - Acceptance activities
313921 CFR 820.140Lack of or inadequate procedures for handling
317221 CFR 820.198(c)Investigation of device failures
323321 CFR 820.72(a)Calibration, Inspection, etc. Procedures Lack of or Inadequ
323521 CFR 820.72(a)Equipment control activity documentation
367121 CFR 820.25(a)Personnel
383721 CFR 820.25(b)Training records
419121 CFR 806.10(a)(1)Report of risk to health
53921 CFR 820.70(b)Production and Process Change Procedures, lack of or Inad.
54121 CFR 820.70(c)Environmental control Lack of or inadequate procedures